| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | SVP,General Counsel &Sec.
2 companies
Levine Mark S. is a Chief Legal Officer at Immunovant, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $9.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 3,027 | $37.92 | $114,778.41 | -0.5% | -27.5% | -39.7% | |
| Nov 22, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 3,252 | $32.78 | $106,598.48 | -0.5% | +14.8% | -18.8% | |
| Oct 25, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 4,107 | $34.66 | $142,348.62 | -1.3% | +15.9% | -10.2% | |
| Aug 24, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 12,286 | $20.30 | $249,406.39 | -1.9% | +63.3% | +62.0% | |
| Jul 26, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 3,917 | $21.63 | $84,724.71 | -1.2% | +62.8% | +29.3% | |
| Apr 25, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 2,633 | $16.29 | $42,891.57 | -0.8% | +35.3% | +78.1% | |
| Jan 26, 2023 | IMVT Immunovant, Inc. | Chief Legal Officer | Sell | 10,156 | $18.51 | $187,987.56 | -4.0% | -8.6% | +117.3% | |
| Jun 1, 2017 | NERV Minerva Neurosciences, Inc. | SVP,General Counsel &Sec. | Sale+OE | 17,500 | $11.00 | $192,500.00 | -100% | - | - | |
| Jan 4, 2017 | NERV Minerva Neurosciences, Inc. | SVP,General Counsel &Sec. | Sale+OE | 17,500 | $12.00 | $210,000.00 | -100% | - | - |